Probst Sabine, Seitz Andreas, Martínez Pereyra Valeria, Hubert Astrid, Becker Alexander, Storm Klaus, Bekeredjian Raffi, Sechtem Udo, Ong Peter
Department of Cardiology, Robert-Bosch-Krankenhaus, Germany.
Eur Heart J Acute Cardiovasc Care. 2021 May 25;10(4):380–387. doi: 10.1177/2048872620932422. Epub 2020 Jun 8.
Coronary spasm is an established cause for myocardial infarction with unobstructed coronary arteries, and can be diagnosed using intracoronary acetylcholine testing. However, it has been questioned whether such testing is feasible and safe in the acute phase. The aim of this study was to assess the frequency of coronary spasm and the safety of the acetylcholine test in patients with myocardial infarction with unobstructed coronary arteries compared to patients with stable angina and unobstructed coronaries.
One hundred and eighty selected patients (52% women, mean age 62±13 years) with either myocardial infarction with unobstructed coronary arteries (=80) or stable angina and unobstructed coronaries (=100) were enrolled from 2007-2018. All patients underwent the acetylcholine test according to a standardised protocol immediately after diagnostic angiography. Apart from assessment of clinical, demographic and risk factor data, side effects and complications during the acetylcholine test were recorded.
Overall, epicardial spasm was found in 26% with a higher prevalence among the myocardial infarction with unobstructed coronary arteries compared to the stable angina patients (35% vs 19%, =0.017). Microvascular spasm was found in 42% with a higher prevalence among the stable patients compared to the myocardial infarction with unobstructed coronary arteries cohort (53% vs 29%, =0.0014). There were no statistically significant differences in the rate of side effects (16% vs 14%, =0.674) or complications (1% vs 2.5%, =0.438) between the two groups. None of the patients experienced irreversible complications.
Coronary spasm is a frequent cause for myocardial infarction with unobstructed coronary arteries. Spasm provocation testing using acetylcholine is feasible in such patients in the acute phase. The complication rate during acetylcholine testing in myocardial infarction with unobstructed coronary arteries patients is low and comparable to patients with stable angina.
冠状动脉痉挛是冠状动脉通畅情况下心肌梗死的既定病因,可通过冠状动脉内乙酰胆碱试验进行诊断。然而,有人质疑这种检测在急性期是否可行和安全。本研究的目的是评估冠状动脉通畅的心肌梗死患者与稳定型心绞痛且冠状动脉通畅的患者相比,冠状动脉痉挛的发生率以及乙酰胆碱试验的安全性。
从2007年至2018年纳入了180例选定患者(女性占52%,平均年龄62±13岁),其中冠状动脉通畅的心肌梗死患者80例,稳定型心绞痛且冠状动脉通畅的患者100例。所有患者在诊断性血管造影后立即按照标准化方案进行乙酰胆碱试验。除了评估临床、人口统计学和危险因素数据外,还记录了乙酰胆碱试验期间的副作用和并发症。
总体而言,26%的患者发现有冠状动脉痉挛,冠状动脉通畅的心肌梗死患者的发生率高于稳定型心绞痛患者(35%对19%,P=0.017)。42%的患者发现有微血管痉挛,稳定型患者的发生率高于冠状动脉通畅的心肌梗死患者队列(53%对29%,P=0.0014)。两组之间副作用发生率(16%对14%,P=0.674)或并发症发生率(1%对2.5%,P=0.438)无统计学显著差异。所有患者均未发生不可逆并发症。
冠状动脉痉挛是冠状动脉通畅情况下心肌梗死的常见病因。在急性期,使用乙酰胆碱进行痉挛激发试验在此类患者中是可行的。冠状动脉通畅的心肌梗死患者在乙酰胆碱试验期间的并发症发生率较低,与稳定型心绞痛患者相当。